Sale!

OPTN Gene Amyotrophic lateral sclerosis type 12 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the OPTN gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) Type 12. ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.

This genetic test is crucial for individuals with a family history of ALS or those showing symptoms of the disease, as it can provide a definitive diagnosis of ALS Type 12. Early detection through genetic testing allows for better management of the condition, including planning for treatment and supportive care.

The test involves a simple blood draw or a cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The laboratory employs cutting-edge technology to accurately identify mutations in the OPTN gene, ensuring reliable results.

The cost of the OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for those affected by this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

OPTN Gene Amyotrophic lateral sclerosis type 12 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for OPTN Gene Amyotrophic lateral sclerosis type 12 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with OPTN Gene Amyotrophic lateral sclerosis type 12

Test Details

The OPTN gene is associated with Amyotrophic lateral sclerosis (ALS) type 12, which is a rare form of ALS. This genetic test is a Next Generation Sequencing (NGS) test that analyzes the OPTN gene to identify any mutations or changes that may be associated with ALS type 12. The test can help diagnose ALS type 12 in individuals who are experiencing symptoms of the disease, or it can be used to determine if individuals with a family history of ALS type 12 are at risk of developing the disease. Early diagnosis can help individuals receive appropriate treatment and support to manage the symptoms of the disease. It is important to note that this test is not a diagnostic tool on its own and should be used in conjunction with other clinical and laboratory tests.

Test Name OPTN Gene Amyotrophic lateral sclerosis type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for OPTN Gene Amyotrophic lateral sclerosis type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with OPTN Gene Amyotrophic lateral sclerosis type 12
Test Details

The OPTN gene is associated with Amyotrophic lateral sclerosis (ALS) type 12, which is a rare form of ALS. This genetic test is a Next Generation Sequencing (NGS) test that analyzes the OPTN gene to identify any mutations or changes that may be associated with ALS type 12. The test can help diagnose ALS type 12 in individuals who are experiencing symptoms of the disease, or it can be used to determine if individuals with a family history of ALS type 12 are at risk of developing the disease. Early diagnosis can help individuals receive appropriate treatment and support to manage the symptoms of the disease. It is important to note that this test is not a diagnostic tool on its own and should be used in conjunction with other clinical and laboratory tests.